Profile
Prior to co-founding CapitalWorks, Mr. Marshall was Chief Investment Officer and the Lead Portfolio Manager of the Mid Cap Growth and the Large Cap Growth product areas at Nicholas-Applegate Capital Management.
He was also President of the Nicholas-Applegate Growth Equity Fund.
Under his direct leadership, client assets grew from $390 million in 1989 to approximately $5 billion in 1997.
Prior to joining Nicholas-Applegate in 1989, he was Managing Director of Equity Investments at Pacific Century Advisors (PCA).
At PCA, he was responsible for the co-management of growth equity accounts.
In addition, he led the equity section of the investment management department and was portfolio manager at San Diego Trust & Savings Bank from 1983 to 1986.
He also worked with Howard, Weil, Labouisse, Fredrichs Inc., a broker/dealer, and Proctor & Gamble Company.
Mr. Marshall earned his BBA and his MBA from Southern Methodist University.
Mr. Marshall has been in the investment industry since 1982.
Former positions of John C. Mashall
| Companies | Position | End |
|---|---|---|
Harlingwood Capital Management
Harlingwood Capital Management Investment ManagersFinance Harlingwood Capital Management offers two primary investment strategies: long/short US equity hedge and small-cap growth. Their long/short US equity hedge strategy is absolute return driven, investing across all US market-cap segments. They focus on strong growth companies on the long side and companies experiencing deteriorating fundamentals on the short side. The small-cap growth strategy is invested with the objective of long-term growth of capital. Small- and micro-cap equities are selected from a universe of high growth US companies. At time of annual benchmark reconstruction, purchase ceilings are set for this universe by matching to the largest (market capitalization) company in the Russell 2000 Growth index. They tend to focus on the technology services, commercials services and health technology sectors. Harlingwood maintains a medium turnover rate. | Analyst-Equity | 27/02/2007 |
Nicholas-Applegate Capital Management
Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate. | Chief Investment Officer | 28/02/1998 |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | - |
Howard Weil Labouisse Friedrichs, Inc.
Howard Weil Labouisse Friedrichs, Inc. Investment Banks/BrokersFinance Provides securities and commodities services | Corporate Officer/Principal | - |
Training of John C. Mashall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Nicholas-Applegate Capital Management
Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate. | Finance |
Harlingwood Capital Management
Harlingwood Capital Management Investment ManagersFinance Harlingwood Capital Management offers two primary investment strategies: long/short US equity hedge and small-cap growth. Their long/short US equity hedge strategy is absolute return driven, investing across all US market-cap segments. They focus on strong growth companies on the long side and companies experiencing deteriorating fundamentals on the short side. The small-cap growth strategy is invested with the objective of long-term growth of capital. Small- and micro-cap equities are selected from a universe of high growth US companies. At time of annual benchmark reconstruction, purchase ceilings are set for this universe by matching to the largest (market capitalization) company in the Russell 2000 Growth index. They tend to focus on the technology services, commercials services and health technology sectors. Harlingwood maintains a medium turnover rate. | Finance |
Southern Methodist University
Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard Weil Labouisse Friedrichs, Inc.
Howard Weil Labouisse Friedrichs, Inc. Investment Banks/BrokersFinance Provides securities and commodities services | Finance |
Procter & Gamble Pharmaceuticals, Inc.
Procter & Gamble Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- John C. Mashall
















